Navigation Links
BP and Prostate Problems Drug Effective in Treating PTSD Nightmares

A generic drug already used for high blood pressure and prostate problems has been found to improve// sleep and lessen nightmares in veterans with posttraumatic stress disorder (PTSD).

"This is the first drug that has been demonstrated effective for PTSD nightmares and sleep disruption," said Murray A. Raskind, MD, executive director of the mental health service at the Veterans Affairs Puget Sound Health Care System and lead author of a study appearing April 15 in Biological Psychiatry.

The randomized trial of 40 veterans compared a nightly dose of prazosin (PRAISE-oh-sin) with placebo over eight weeks. Participants continued to take other prescribed medications over the course of the trial.

At the end of the study, veterans randomized to prazosin reported significantly improved sleep quality, reduced trauma nightmares, a better overall sense of well being, and an improved ability to function.

"These nighttime symptoms are heavily troublesome to veterans," said Raskind, who also is director of VA’s VISN 20 (Veterans Integrated Service Network #20) Mental Illness Research, Education and Clinical Centers program (MIRECC). "If you get the nighttime symptoms under control, veterans feel better all around."

Raskind, also a professor of psychiatry and behavioral sciences at the University of Washington, estimates that of the 10 million U.S. veterans and civilians with PTSD, about half have trauma-related nightmares that could be helped with the drug.

Participants were given 1 mg of prazosin per day for the first three days. The dose was gradually increased over the first four weeks to a maximum of 15 mg at bedtime. The average dose of prazosin in the trial was 13.3 mg. By comparison, typical prazosin doses for controlling blood pressure or treating prostate problems range from 3 mg to 30 mg per day in divided doses.

The drug did not affect blood pressure compared to placebo, th
'"/>




Page: 1 2 3

Related medicine news :

1. Cancer Doctors Okays Controversial Prostate Therapy
2. Radioactive Seeds used in Prostate Cancer treatment can migrate with the body
3. New Prostate Cancer Vaccine Shows Promise
4. Hormone Therapy applicable for Prostate Cancer
5. Prostate cancer and Vitamins
6. Response to chemotherapy could be measured by Prostate-Specific Antigen Doubling Time
7. Early Detection Of Prostate Cancer
8. Awareness increase Prostate cancer detection
9. Better Prostate Cancer Test
10. Stopping Prostate Cancer from Spreading
11. Drug might prevent Prostate Cancer Spread
Post Your Comments:
(Date:5/13/2008)... Annually, allergies and asthma strike,one out of ...eezing and,wheezing -- as well as $6 billion in do... right air treatment and cleaning strategies in,pl...ving environment and,help avoid allergy suffering,...ident of Sylvane.com ( http://www.sylvane.com )., ...
(Date:5/12/2008)...ered treatments which have helped millions of peop...diseases have been awarded the prestigious 2008 Dr...unced today. , Emeritus Professor Sir Ravinder M...rrying out research together at Imperial College L... award by an international committee including Nob...
(Date:5/12/2008)...AGEN, Denmark, May 12,/PRNewswire-FirstCall/ -- Wa...the United States Food and Drug Administration (FD... Taclonex Scalp(R) (calcipotriene 0.005% and,betam...LEO Pharma submitted,the NDA for Taclonex Scalp(R)...opical suspension containing a combination of calc...
(Date:5/12/2008)...RNewswire/ -- Emphasys Medical Inc.,today announc... of the,company,s Zephyr(R) Endobronchial Valve (E...nce of the American Thoracic Society (ATS) occurri...18, 9:30-11:00 a.m. (ET), Metro Toronto Convention...s in Emphysema Treatment: Lung Volume,Reduction an...
Breaking Medicine News(10 mins):Health News:Simple Steps to a Healthier, Allergy-Free Home 2Health News:Simple Steps to a Healthier, Allergy-Free Home 3Health News:Researchers who helped millions with arthritis receive prestigious Janssen Award 2Health News:Researchers who helped millions with arthritis receive prestigious Janssen Award 3Health News:Researchers who helped millions with arthritis receive prestigious Janssen Award 4Health News:FDA Approves Taclonex Scalp(R) - Once Daily Therapy for Treatment of Moderate to Severe Scalp Psoriasis 2Health News:FDA Approves Taclonex Scalp(R) - Once Daily Therapy for Treatment of Moderate to Severe Scalp Psoriasis 3Health News:FDA Approves Taclonex Scalp(R) - Once Daily Therapy for Treatment of Moderate to Severe Scalp Psoriasis 4Health News:Emphasys Medical to Present VENT Clinical Trial Data at ATS 2008 2
...particles in occupational settings and in the envi...r risk. The December// Journal of Occupational and...he American College of Occupational and Environmen...ue providing updates on particles and cancer. "A ...
...red that women treated for ovarian cancer are at i...urrence if their tumor cells have high// levels of...nd slows down cell death, both hallmarks of malign...at testing for NAC-1 protein in cancer tissue remo...
...BIC) is a natural soy-based substance. A US based ...s with a disease similar to multiple// sclerosis. ...tis (EAE) received BBIC, while another group of an...he same disease received a placebo. "Animals that...
...mammography unit can detect breast tumors as tiny ...e it a valuable complementary// imaging technique ...o helped develop the technology along with industr...ealthcare. This new technique, Molecular Breast ...
Other Medicine News:Health News:Inhaled Particles Increases the Risk of Lung Cancer 2Health News:'Clumping' Protein Linked to Return of Ovarian Cancer 2Health News:A New Gamma Camera Technique for the Detection of Small Breast Tumors 2Health News:A New Gamma Camera Technique for the Detection of Small Breast Tumors 3
(Date:5/8/2008)...trated significant improvement in ADHD symptoms in... -- Shire plc (LSE: SHP,Nasdaq: SHPGY), the globa...nted the results of a phase III pivotal study in w... in Attention Deficit Hyperactivity,Disorder (ADHD...cy,endpoints., "Adults with ADHD often find it ch...
(Date:5/8/2008)... May 8 /- Alpharma Inc. (NY...any, today announced results from,clinical trials ...extended-release with sequestered naltrexone hydro...t features addressing abuse liability,alongside a ... and II,studies, presented at the 27th Annual Scie...
(Date:5/8/2008)...ovides "Blueprint" to Produce Therapeutic Proteins.../PRNewswire-USNewswire/ -- Using gene,therapy, pla...ins through,skin flaps placed on cancerous tumors ...e, according to a study in the May issue of Plasti...cal journal of the American,Society of Plastic Sur...
(Date:5/8/2008)...ed at the 27th Annual Meeting of the American Pain...MYRNA, Ga., May 8 /- Patients treated...f from diabetic neuropathic pain (DNP),compared t...ented at the,27th annual meeting of the American P...rst placebo-controlled trial of a diabetic neuropa...
Breaking Medicine Technology:Results of the Phase III Pivotal Study of VYVANSE(TM) (Lisdexamfetamine Dimesylate) for the Treatment of ADHD in Adults Presented at National Scientific Meeting of Psychiatrists 2Results of the Phase III Pivotal Study of VYVANSE(TM) (Lisdexamfetamine Dimesylate) for the Treatment of ADHD in Adults Presented at National Scientific Meeting of Psychiatrists 3Results of the Phase III Pivotal Study of VYVANSE(TM) (Lisdexamfetamine Dimesylate) for the Treatment of ADHD in Adults Presented at National Scientific Meeting of Psychiatrists 4Results of the Phase III Pivotal Study of VYVANSE(TM) (Lisdexamfetamine Dimesylate) for the Treatment of ADHD in Adults Presented at National Scientific Meeting of Psychiatrists 5Alpharma Presents Data Addressing Abuse Liability Features, Safety and Efficacy on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) at the American Pain Society Annual Scientific Session 2Alpharma Presents Data Addressing Abuse Liability Features, Safety and Efficacy on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) at the American Pain Society Annual Scientific Session 3Alpharma Presents Data Addressing Abuse Liability Features, Safety and Efficacy on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) at the American Pain Society Annual Scientific Session 4Alpharma Presents Data Addressing Abuse Liability Features, Safety and Efficacy on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) at the American Pain Society Annual Scientific Session 5Alpharma Presents Data Addressing Abuse Liability Features, Safety and Efficacy on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) at the American Pain Society Annual Scientific Session 6Alpharma Presents Data Addressing Abuse Liability Features, Safety and Efficacy on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) at the American Pain Society Annual Scientific Session 7Skin Flaps Deliver Cancer-fighting Therapy, ASPS Study Reveals 2Skin Flaps Deliver Cancer-fighting Therapy, ASPS Study Reveals 3New Lacosamide Data Provides Evidence for Long-Term Efficacy in Diabetic Neuropathic Pain 2New Lacosamide Data Provides Evidence for Long-Term Efficacy in Diabetic Neuropathic Pain 3New Lacosamide Data Provides Evidence for Long-Term Efficacy in Diabetic Neuropathic Pain 4Can you rescue a rainforest 3F The answer may be yes 2647 1Can you rescue a rainforest 3F The answer may be yes 2647 2IntelliPharmaCeutics Announces Successful Completion of a Pilot Clinical Trial for its Abuse and Alcohol Resistant Sustained Release Oxycodone 4230 1IntelliPharmaCeutics Announces Successful Completion of a Pilot Clinical Trial for its Abuse and Alcohol Resistant Sustained Release Oxycodone 4230 2IntelliPharmaCeutics Announces Successful Completion of a Pilot Clinical Trial for its Abuse and Alcohol Resistant Sustained Release Oxycodone 4230 3Schizophrenia Tied to Multiple Genetic Errors 15335 1Schizophrenia Tied to Multiple Genetic Errors 15335 2Schizophrenia Tied to Multiple Genetic Errors 15335 3California Eye Surgeons Journey to Vietnam to Perform Sight Saving Surgery 15333 1California Eye Surgeons Journey to Vietnam to Perform Sight Saving Surgery 15333 2California Eye Surgeons Journey to Vietnam to Perform Sight Saving Surgery 15333 3California Eye Surgeons Journey to Vietnam to Perform Sight Saving Surgery 15333 4
...RE)--May 23, 2007 - Northfield,Laboratories, Inc. ...al Phase III trauma trial with PolyHeme(R), its hu...l substitute. The,trial was designed to seek an in...ing red blood cell loss when transfusion is,requir...use,interchangeably with blood. This indication ad...
...y 22, 2007 - MIV Therapeutics,(OTCBB:MIVT) (FWB:MI...atible coatings and advanced drug delivery systems...edical devices, is,pleased to announce that result...olymer free Hydroxyapatite-coated drug-eluting,car...e presented at,this weeks EuroPCR 2007 conference ...
Other Medicine Technology:Northfield Laboratories Reports Results of Pivotal Phase III Trauma,Study 2Northfield Laboratories Reports Results of Pivotal Phase III Trauma,Study 3Northfield Laboratories Reports Results of Pivotal Phase III Trauma,Study 4Northfield Laboratories Reports Results of Pivotal Phase III Trauma,Study 5Northfield Laboratories Reports Results of Pivotal Phase III Trauma,Study 6Northfield Laboratories Reports Results of Pivotal Phase III Trauma,Study 7Northfield Laboratories Reports Results of Pivotal Phase III Trauma,Study 8MIV Therapeutics Announces Renowned Researcher to Detail Milestone,Pre-Clinical Results at Prominent International Conference EuroPCR,2007 2MIV Therapeutics Announces Renowned Researcher to Detail Milestone,Pre-Clinical Results at Prominent International Conference EuroPCR,2007 3MIV Therapeutics Announces Renowned Researcher to Detail Milestone,Pre-Clinical Results at Prominent International Conference EuroPCR,2007 4
...boratory and a worldwide leader in innovative labo...tensive test menu of highly complex and unique med...ed by the University of Utah, ARUP Laboratories' c...ersity teaching hospitals and children's hospitals...
...boratory and a worldwide leader in innovative labo...tensive test menu of highly complex and unique med...ed by the University of Utah, ARUP Laboratories' c...ersity teaching hospitals and children's hospitals...
...boratory and a worldwide leader in innovative labo...tensive test menu of highly complex and unique med...ed by the University of Utah, ARUP Laboratories' c...ersity teaching hospitals and children's hospitals...
...boratory and a worldwide leader in innovative labo...tensive test menu of highly complex and unique med...ed by the University of Utah, ARUP Laboratories' c...ersity teaching hospitals and children's hospitals...
Medicine Products: